Exactly....the hardest bit is the ASX listed side of things...but they aren't making that any easier on themselves!
OCC Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
I88 History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
